Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SSGJ-613 for Prophylaxis Against Acute Gouty Arthritis Flares
NCT07708181Phase 2Not yet recruiting
- Sponsor
- 3S Guojian Pharmaceutical
- Start
- Aug 2026
- Primary completion
- Aug 2027
01
Overview
A Phase 2 trial of SSGJ-613 in gouty arthritis, sponsored by 3S Guojian Pharmaceutical. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
SSGJ-613
03
Conditions
gouty arthritis
Beyond the preview
Go deeper on NCT07708181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07708181.